Title: Social Network Interventions to Reduce Race Disparities in Living Kidney Donation
Agency: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
PRI investigators, led by JD Daw, have received a new R01 award to study racial disparities in living donor transplants among patients needing kidney transplants. Co-investigators include Ashton Verdery and Selena Ortiz, HPA, PSU. End stage renal disease (ESRD) is among the ten leading causes of death for Americans, and its incidence and prevalence are rising, especially among non-white groups. Kidney transplantation is the most effective treatment option for many Americans with ESRD, but the number of Americans needing kidneys is currently much larger and rising much faster than the current number of transplants performed. Patients who seek transplants have one of two options: wait for a kidney from a deceased donor to become available, or obtain a transplant from a living kidney donor (LDD KT). They will conduct a multi-center study to collect novel data on transplant candidates’ social networks and to test promising social interventions that could reduce barriers to LDD KT. They hypothesize that the primary barrier to eliminating disparities in LDD KT and promoting greater utilization of LDD KT for all groups is social, not biomedical, in origin. LDD KT has substantial potential to solve public health challenges around the growing prevalence of ESRD, and the basic and applied knowledge that they will develop as part of this proposal will help to unlock this potential.
Title: Social Network Interventions to Reduce Race Disparities in Living Kidney Donation
Agency: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
PRI investigators, led by JD Daw, have received a new R01 award to study racial disparities in living donor transplants among patients needing kidney transplants. Co-investigators include Ashton Verdery and Selena Ortiz, HPA, PSU. End stage renal disease (ESRD) is among the ten leading causes of death for Americans, and its incidence and prevalence are rising, especially among non-white groups. Kidney transplantation is the most effective treatment option for many Americans with ESRD, but the number of Americans needing kidneys is currently much larger and rising much faster than the current number of transplants performed. Patients who seek transplants have one of two options: wait for a kidney from a deceased donor to become available, or obtain a transplant from a living kidney donor (LDD KT). They will conduct a multi-center study to collect novel data on transplant candidates’ social networks and to test promising social interventions that could reduce barriers to LDD KT. They hypothesize that the primary barrier to eliminating disparities in LDD KT and promoting greater utilization of LDD KT for all groups is social, not biomedical, in origin. LDD KT has substantial potential to solve public health challenges around the growing prevalence of ESRD, and the basic and applied knowledge that they will develop as part of this proposal will help to unlock this potential.